2022–2023 mpox outbreak in Brazil

Overview of the 2022–2023 mpox outbreak in Brazil

The 2022–2023 mpox outbreak in Brazil is part of the global 2022–2023 mpox outbreak, which saw a significant rise in cases of mpox (formerly known as monkeypox) across multiple countries. This outbreak in Brazil has been notable for its rapid spread and the public health response it necessitated.

Background

Stages of monkeypox lesion development

Mpox is a viral disease caused by the monkeypox virus, a member of the Orthopoxvirus genus. The disease is characterized by symptoms such as fever, headache, muscle aches, and a distinctive rash that progresses through several stages before crusting and falling off. Historically, mpox has been endemic to certain regions in Africa, but the 2022–2023 outbreak marked a significant geographic expansion.

Outbreak in Brazil

The first confirmed case of mpox in Brazil was reported in June 2022. The outbreak quickly escalated, with cases spreading across multiple states. The Brazilian Ministry of Health implemented various measures to control the spread, including public health campaigns and vaccination efforts.

Epidemiology

Map of monkeypox outbreak cases in Brazil

The outbreak in Brazil has been concentrated in urban areas, with the highest number of cases reported in São Paulo, Rio de Janeiro, and Minas Gerais. The demographic most affected includes young adults, particularly those with multiple sexual partners. The transmission in Brazil has been primarily through close contact, including sexual contact.

Public Health Response

The Brazilian government, in collaboration with international health organizations, has undertaken several initiatives to curb the outbreak. These include:

• Vaccination Campaigns: Targeted vaccination efforts have been directed at high-risk populations.
• Public Awareness: Information campaigns have been launched to educate the public about symptoms and prevention methods.
• Surveillance and Reporting: Enhanced surveillance systems have been put in place to track and report new cases promptly.

Challenges

The outbreak has posed several challenges, including:

• Vaccine Availability: Limited availability of vaccines has been a significant hurdle in controlling the spread.
• Public Perception: Misinformation and stigma associated with the disease have affected public health efforts.
• Healthcare System Strain: The outbreak has added pressure to an already strained healthcare system, still recovering from the COVID-19 pandemic.

Related pages

• Mpox
• 2022–2023 mpox outbreak
• Public health in Brazil